Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Marijuana Dependence: early-phase trial registry

A small indexed set (7 trials) with no open enrollment listed right now.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · none currently recruiting · #2,497 of 28,707 conditions by registered trial count

Marijuana Dependence: 7 US clinical trials tracked, none currently recruiting.

Marijuana Dependence is the subject of 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Medical University of South Carolina, running 4 of these trials.

Enrollment posture brief

Registry condition marijuana-dependence

OPEN 0 | RECR 0% | LATE 1 | EARLY 3 | RANK #2497 | SPON 4

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

ACL Tear71.4%ACL57.1%Acute Myelogenous Leukemia42.9%Acne Scars28.6%Marijuana Dependence (this)0%
Open-enrollment share among volume-matched conditions near Marijuana Dependence

Marijuana Dependence has no open enrollment in this registry pull (7 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Marijuana Dependence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Marijuana Dependence is recruiting below its size-band peers.

    0 of 7 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Marijuana Dependence research.

    Medical University of South Carolina accounts for 4 of 7 trials (57.1%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Marijuana Dependence trials plan to enrol fewer than 100 people.

    Median target enrolment is 61 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.

  4. Marijuana Dependence research is mostly interventional.

    7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 23Phase 41

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 4 1

Named interventions

Most-linked intervention names on Marijuana Dependence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
4 trials
Oxytocin Drug
2 trials
Saline Drug
2 trials
BRENDA therapy Behavioral
1 trials
Individualized Assessment & Treatment Behavioral
1 trials
Vilazodone Drug
1 trials
Marijuana Drug
1 trials
Baclofen Drug
1 trials

US sites by state

Facility locations filed on Marijuana Dependence trials. A trial with sites in several states counts in each.

South Carolina 4 trials
Pennsylvania 1 trials
New York 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Marijuana Dependence page

7 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Marijuana Dependence condition card totals 7 registered trials; most-linked intervention Placebo; top US site state South Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.